Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desferal for Prevention of ARDS in COVID-19
NCT04389801Phase 4Unknown
- Start
- Jun 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of deferoxamine in coronavirus disease 2019 (COVID-19). Status: unknown.
02
Drugs
deferoxamine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04389801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04389801.